Long‐Term Safety and Efficacy of Certolizumab Pegol Therapy in Patients With Moderate to Severe Crohn's Disease: 5‐Year Results: 1821. (October 2015) - Ptak, Theadore; Younes, Ziad; Shafran, Ira; Lee, Scott; Miner, Philip B.; Kayhan, Cem; Kosutic, Gordana; Coarse, Jason; Hasan, Iram; Spearman, Marshall; Sandborn, William J.